How to Avoid Getting "Tyked" Off When Learning About New JAK Inhibitors In Psoriasis

from Derms and Conditions · host Dermsquared

Live from The Wynn Hotel and Casino in Las Vegas, NV, episode 13 of Derms and Conditions, has our host James Q. Del Rosso, DO speaking with Bruce Strober, MD in person at the 2021 Fall Clinical Dermatology Conference. First Dr. Strober discusses older biologic agents in psoriasis and how JAK inhibitors offer improved efficacy while not compromising on safety. Dr. Strober further discusses in depth how certain JAK inhibitors interact with TYK2 and what he thinks are the most important points regarding this pathway in psoriasis pathophysiology. Finally, Dr. Strober discusses in detail why allosteric binding offers improved specificity in JAK inhibition.

Episode metadata supplied by the publisher feed · Published Oct 28, 2021

Embed this episode

Attribution link and audio player

Ready to play

How to Avoid Getting "Tyked" Off When Learning About New JAK Inhibitors In Psoriasis

0:00 11:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Derms and Conditions?

This episode is 11 minutes long.

When was this Derms and Conditions episode published?

This episode was published on October 28, 2021.

Can I download this Derms and Conditions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!